Ensuring Representative Clinical Trials: Design, Measurement, Action

• Inclusive Study Design: How do we examine eligibility criteria and embed recruitment strategies to reach intended-use populations?
• Real‑Time Measurement: What metrics help us uncover barriers to participation and how we demonstrate progress?
• Portfolio‑Level Action: How do we translate cross-study trends into action across clinical programs?

Speakers:

Molly Kerrigan

Patient Science Lead, Patient Safety Data & Analytics

AstraZeneca